{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:42:12Z","timestamp":1790883732904,"version":"4.1.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>Plasma products, including fresh frozen plasma, are administered extensively in a variety of settings from massive transfusion to vitamin K antagonist reversal. Despite the widespread use of plasma as a hemostatic agent in bleeding patients, its effect in comparison with other available choices of hemostatic therapies is unclear. We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, PubMed Central, and databases of ongoing trials for randomized controlled trials that assessed the efficacy and\/or safety of therapeutic plasma as an intervention to treat bleeding patients compared with other interventions or placebo. Of 1243 unique publications retrieved in our initial search, no randomized controlled trials were identified. Four nonrandomized studies described the effect of therapeutic plasma in bleeding patients; however, data gathered from these studies did not allow for comparison with other therapeutic interventions primarily as a result of the low number of patients and the use of different (or lack of) comparators. We identified two ongoing trials investigating the efficacy and safety of therapeutic plasma, respectively; however, no data have been released as yet. Although plasma is used extensively in the treatment of bleeding patients, evidence from randomized controlled trials comparing its effect with those of other therapeutic interventions is currently lacking.<\/jats:p>","DOI":"10.1213\/ane.0000000000001897","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T11:41:55Z","timestamp":1490096515000},"page":"1268-1276","source":"Crossref","is-referenced-by-count":24,"title":["Therapeutic Plasma Transfusion in Bleeding Patients: A Systematic Review"],"prefix":"10.1213","volume":"124","author":[{"given":"Jerrold H.","family":"Levy","sequence":"first","affiliation":[{"name":"Department of Anesthesia and Intensive Care, Evangelical Hospital Vienna, Hans-Sachs-Gasse, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Grottke","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, Evangelical Hospital Vienna, Hans-Sachs-Gasse, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Fries","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, Evangelical Hospital Vienna, Hans-Sachs-Gasse, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Kozek-Langenecker","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, Evangelical Hospital Vienna, Hans-Sachs-Gasse, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230812","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1111\/jocn.12936","article-title":"Excessive bleeding predictors after cardiac surgery in adults: integrative review.","volume":"24","author":"Lopes","year":"2015","journal-title":"J Clin Nurs"},{"key":"R2-20230812","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/TA.0000000000000707","article-title":"The tissue factor pathway mediates both activation of coagulation and coagulopathy after injury.","volume":"79","author":"Howard","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"key":"R3-20230812","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood.V94.7.2169.419k22_2169_2178","article-title":"\u2018Normal\u2019 thrombin generation.","volume":"94","author":"Butenas","year":"1999","journal-title":"Blood"},{"key":"R4-20230812","first-page":"360","article-title":"Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates.","volume":"81","author":"Hiippala","year":"1995","journal-title":"Anesth Analg"},{"key":"R5-20230812","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/trf.12431","article-title":"Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy.","volume":"54","author":"Levy","year":"2014","journal-title":"Transfusion"},{"key":"R6-20230812","first-page":"CD008864","article-title":"Fibrinogen concentrate in bleeding patients.","volume":"8","author":"Wikkels\u00f8","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-20230812","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/bja\/aeu004","article-title":"III. Fibrinogen concentrate: clinical reality and cautious Cochrane recommendation.","volume":"112","author":"Kozek-Langenecker","year":"2014","journal-title":"Br J Anaesth"},{"key":"R8-20230812","first-page":"132","article-title":"Recommendations for the transfusion of plasma and platelets.","volume":"7","author":"Liumbruno","year":"2009","journal-title":"Blood Transfus"},{"issue":"suppl 1","key":"R9-20230812","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1111\/j.1537-2995.2012.03663.x","article-title":"Adverse effects of plasma transfusion.","volume":"52","author":"Pandey","year":"2012","journal-title":"Transfusion"},{"key":"R10-20230812","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2141.2006.06355.x","article-title":"Guidelines on the management of massive blood loss.","volume":"135","author":"Stainsby","year":"2006","journal-title":"Br J Haematol"},{"key":"R11-20230812","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2141.2004.04972.x","article-title":"Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant.","volume":"126","author":"O\u2019Shaughnessy","year":"2004","journal-title":"Br J Haematol"},{"key":"R12-20230812","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5694\/mja12.10614","article-title":"An update of consensus guidelines for warfarin reversal.","volume":"198","author":"Tran","year":"2013","journal-title":"Med J Aust"},{"key":"R13-20230812","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol"},{"issue":"suppl 1","key":"R14-20230812","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/j.1537-2995.2012.03689.x","article-title":"The plasma wars: a history.","volume":"52","author":"Schmidt","year":"2012","journal-title":"Transfusion"},{"issue":"suppl 1","key":"R15-20230812","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1111\/j.1537-2995.2012.03622.x","article-title":"Plasma components: properties, differences, and uses.","volume":"52","author":"Benjamin","year":"2012","journal-title":"Transfusion"},{"key":"R16-20230812","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.transci.2014.07.006","article-title":"Economic evaluation of pooled solvent\/detergent treated plasma versus single donor fresh-frozen plasma in patients receiving plasma transfusions in the United States.","volume":"51","author":"Huisman","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"R17-20230812","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/TA.0000000000000629","article-title":"All plasma products are not created equal: characterizing differences between plasma products.","volume":"78","author":"Spinella","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"key":"R19-20230812","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1111\/j.1537-2995.2012.03691.x","article-title":"Plasma transfusion for bedside, radiologically guided, and operating room invasive procedures.","volume":"52(suppl 1)","author":"Desborough","year":"2012","journal-title":"Transfusion"},{"key":"R20-20230812","doi-asserted-by":"crossref","first-page":"R239","DOI":"10.1186\/cc10488","article-title":"Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review.","volume":"15","author":"Kozek-Langenecker","year":"2011","journal-title":"Crit Care"},{"key":"R21-20230812","first-page":"221","article-title":"Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome.","volume":"67","author":"Watson","year":"2009","journal-title":"J Trauma"},{"key":"R22-20230812","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jamcollsurg.2010.01.031","article-title":"Impact of plasma transfusion in trauma patients who do not require massive transfusion.","volume":"210","author":"Inaba","year":"2010","journal-title":"J Am Coll Surg"},{"key":"R23-20230812","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/CCM.0b013e318168f89d","article-title":"Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection.","volume":"36","author":"Sarani","year":"2008","journal-title":"Crit Care Med"},{"key":"R24-20230812","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1378\/chest.06-3048","article-title":"Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients.","volume":"131","author":"Khan","year":"2007","journal-title":"Chest"},{"key":"R25-20230812","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.injury.2012.08.047","article-title":"The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma.","volume":"44","author":"Innerhofer","year":"2013","journal-title":"Injury"},{"key":"R26-20230812","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1537-2995.2010.02816.x","article-title":"Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients.","volume":"51","author":"Li","year":"2011","journal-title":"Transfusion"},{"key":"R28-20230812","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1537-2995.2011.03330.x","article-title":"Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services.","volume":"52","author":"Lin","year":"2012","journal-title":"Transfusion"},{"key":"R29-20230812","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1537-2995.2008.01948.x","article-title":"Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma.","volume":"49","author":"Chapman","year":"2009","journal-title":"Transfusion"},{"key":"R30-20230812","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1423-0410.2011.01570.x","article-title":"Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.","volume":"103","author":"Lucas","year":"2012","journal-title":"Vox Sang"},{"key":"R32-20230812","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000323552","article-title":"The use of solvent\/detergent treatment in pathogen reduction of plasma.","volume":"38","author":"Hellstern","year":"2011","journal-title":"Transfus Med Hemother"},{"key":"R33-20230812","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/EJA.0b013e32835f4d5b","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology.","volume":"30","author":"Kozek-Langenecker","year":"2013","journal-title":"Eur J Anaesthesiol"},{"key":"R34-20230812","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R35-20230812","article-title":"Cochrane handbook for systematic reviews of interventions.","author":"Higgins","year":"2011","journal-title":"The Cochrane Collaboration"},{"key":"R36-20230812","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/pan.12571","article-title":"Prophylactic versus reactive transfusion of thawed plasma in patients undergoing surgical repair of craniosynostosis: a randomized clinical trial.","volume":"25","author":"Pieters","year":"2015","journal-title":"Paediatr Anaesth"},{"key":"R37-20230812","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1160\/TH07-07-0438","article-title":"Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.","volume":"99","author":"Schols","year":"2008","journal-title":"Thromb Haemost"},{"key":"R38-20230812","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1423-0410.2002.00129.x","article-title":"Effects of solvent\/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery.","volume":"82","author":"Haubelt","year":"2002","journal-title":"Vox Sang"},{"key":"R39-20230812","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/trf.12422","article-title":"Fresh-frozen plasma transfusion did not reduce 30-day mortality in patients undergoing cardiopulmonary bypass cardiac surgery with excessive bleeding: the PLASMACARD multicenter cohort study.","volume":"54","author":"Doussau","year":"2014","journal-title":"Transfusion"},{"key":"R40-20230812","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/bja\/aes576","article-title":"Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery.","volume":"110","author":"Solomon","year":"2013","journal-title":"Br J Anaesth"},{"key":"R41-20230812","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.injury.2010.12.015","article-title":"The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion.","volume":"42","author":"Nienaber","year":"2011","journal-title":"Injury"},{"key":"R43-20230812","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1179\/1607845412Y.0000000019","article-title":"Concurrent audit of fresh frozen plasma: experience of a tertiary care hospital.","volume":"17","author":"Pahuja","year":"2012","journal-title":"Hematology"},{"key":"R44-20230812","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/trf.12231","article-title":"Utilization of frozen plasma in Ontario: a provincewide audit reveals a high rate of inappropriate transfusions.","volume":"53","author":"Tinmouth","year":"2013","journal-title":"Transfusion"},{"key":"R45-20230812","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.26719\/2010.16.12.1257","article-title":"Transfusion audit of blood products using the World Health Organization Basic Information Sheet in Qazvin, Islamic Republic of Iran.","volume":"16","author":"Sheikholeslami","year":"2010","journal-title":"East Mediterr Health J"},{"key":"R46-20230812","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1309\/AJCP8WFIQ0JRCSIR","article-title":"A cross-sectional pilot study of blood utilization in 27 hospitals in Northern California.","volume":"142","author":"Bloch","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"R47-20230812","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cll.2014.06.005","article-title":"Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing.","volume":"34","author":"Levy","year":"2014","journal-title":"Clin Lab Med"},{"key":"R48-20230812","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1537-2995.2006.00891.x","article-title":"Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities.","volume":"46","author":"Abdel-Wahab","year":"2006","journal-title":"Transfusion"},{"key":"R49-20230812","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/jth.12351","article-title":"Fresh frozen plasma: the most commonly prescribed hemostatic agent.","volume":"11","author":"Puetz","year":"2013","journal-title":"J Thromb Haemost"},{"key":"R50-20230812","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2141.2004.04973.x","article-title":"Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials.","volume":"126","author":"Stanworth","year":"2004","journal-title":"Br J Haematol"},{"key":"R51-20230812","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/j.1537-2995.2011.03515.x","article-title":"Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials.","volume":"52","author":"Yang","year":"2012","journal-title":"Transfusion"},{"key":"R52-20230812","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1537-2995.2010.02798.x","article-title":"The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children.","volume":"51","author":"Stanworth","year":"2011","journal-title":"Transfusion"},{"key":"R53-20230812","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/cc12685","article-title":"Management of bleeding and coagulopathy following major trauma: an updated European guideline.","volume":"17","author":"Spahn","year":"2013","journal-title":"Crit Care"},{"key":"R54-20230812","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TA.0b013e3182983876","article-title":"The PRospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study.","volume":"75","author":"Holcomb","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"R55-20230812","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/TA.0b013e31828fa3b9","article-title":"Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study.","volume":"75","author":"del Junco","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"R56-20230812","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"key":"R57-20230812","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/anae.13067","article-title":"Haemostatic profile of reconstituted blood in a proposed 1:1:1 ratio of packed red blood cells, platelet concentrate and four different plasma preparations.","volume":"70","author":"Ponschab","year":"2015","journal-title":"Anaesthesia"},{"key":"R58-20230812","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/CCM.0b013e31828a3214","article-title":"Effect of plasma-to-RBC ratios in trauma patients: a cohort study with time-dependent data*.","volume":"41","author":"Halmin","year":"2013","journal-title":"Crit Care Med"},{"key":"R59-20230812","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/ALN.0b013e318245c47b","article-title":"Prevalence of survivor bias in observational studies on fresh frozen plasma: erythrocyte ratios in trauma requiring massive transfusion.","volume":"116","author":"Ho","year":"2012","journal-title":"Anesthesiology"},{"key":"R60-20230812","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1537-2995.2010.02632.x","article-title":"Evidence-based practice guidelines for plasma transfusion.","volume":"50","author":"Roback","year":"2010","journal-title":"Transfusion"},{"key":"R61-20230812","first-page":"CD010654","article-title":"Plasma transfusion strategies for critically ill patients.","volume":"12","author":"Karam","year":"2013","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201704000-00037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:32:06Z","timestamp":1786113126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201704000-00037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000001897","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}